Back

Avineuro advances second drug candidate to clinical development for treatment of Alzheimer’s disease.

San Diego, CA – November 3rd, 2008 – Avineuro Pharmaceuticals, Inc. announced today the completion of preclinical studies of AVN-211, a potent and selective small molecule antagonist of 5-HT6 receptor for treatment of Alzheimer’s disease. These studies demonstrate that AVN-211 is safe and well tolerated, and that it has a favorable pharmacokinetic profile. Based on these and other results, Avineuro Pharmaceuticals, Inc. plans to advance AVN-211 into clinical trials in Q1 2009. Results of the studies will be presented at the 9th International Conference – AD/PD 2009 – Prague, Czech Republic, March 11-15, 2009.

About Avineuro Pharmaceuticals, Inc.:

Avineuro discovers and develops novel small molecules for unmet medical needs in neurology and psychiatry. Avineuro emphasizes a rational approach to drug discovery that combines modern medicinal chemistry with streamlined pre-clinical and clinical development studies, thus allowing a fast transition to proof-of-concept product candidates.

Contact:
Yan Lavrovsky, CEO
Avineuro Pharmaceuticals, Inc.
6605 Nancy Ridge Drive, Suite 126
San Diego, CA 92121
Tel 858-436-1537 / 858-436-1540
Fax 858-228-9798
Email:YLavrovsky@avineuro.com

Back

Avineuro appoints Eliezer Masliah, M.D. to the Scientific Advisory Board

San Diego, CA – November 4th, 2008 – Avineuro Pharmaceuticals, Inc. is pleased to announce that it has appointed Eliezer Masliah, M.D. to its Scientific Advisory Board, effective immediately.

Eliezer Masliah, M.D. is a Professor, Departments of Neurosciences and Pathology, University of California San Diego. Dr. Masliah heads the Experimental Neuropathology Laboratory, which engages foremost in the scientific pursuits of the cellular and molecular mechanisms leading to synaptic damage in neurodegenerative disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and dementia associated with AIDS. Dr. Masliah earned his M.D. in 1983 from the National Autonomous University of Mexico City, Mexico.

Contact:
Yan Lavrovsky, CEO
Avineuro Pharmaceuticals, Inc.
6605 Nancy Ridge Drive, Suite 126
San Diego, CA 92121
Tel 858-436-1537 / 858-436-1540
Fax 858-228-9798
Email:YLavrovsky@avineuro.com

Welcome to WordPress. This is your first post. Edit or delete it, then start blogging!